21-Gene recurrence score decreases receipt of chemotherapy in ER+ early-stage breast cancer: an analysis of the NCDB 2010–2013

Benjamin M. Parsons, Jeffrey Landercasper, Angela L. Smith, Ronald S. Go, Andrew J. Borgert, Leah L. Dietrich

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint

Dive into the research topics of '21-Gene recurrence score decreases receipt of chemotherapy in ER+ early-stage breast cancer: an analysis of the NCDB 2010–2013'. Together they form a unique fingerprint.

Medicine & Life Sciences